Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Buying rates

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Apr 30, 2021 12:50am

129 Views

Post# 33099413

RE:RE:RE:RE:Buying rates

Sally we have had the data that might derisk this play enough for big pharma to potentially get involved pubicialy since Jan 15th. Hard to say at what point pharma will step in but it was very unlikely to see anything in the 7 years preclinical leading up. Now after other acquisitions in the space, RM heating up, Sernova in clinical trials with good data and a device needed for ISP cells its in my opinion now very likely to see a deal.

Canadian doctors are one of the few that can practice in the states so options are open. I'm not sure what Philip has planned sounded like FDA trials from the last presentation. Money wont be an issue if we have a major collaboration.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?